Our team has 80+ years of combined experience utilizing ophthalmic animal models for drug development. We specialize in preclinical ophthalmic studies of pharmacology/efficacy, PK/tox, and eyedrop formulation development. Efficacy models include dry eye, allergic conjunctivitis, corneal neovascularization, laser-induced CNV, STZ-induced diabetes, ischemia/reperfusion, inherited retinal degenerations, quantification of A2E/retinoids, light-induced retinal degeneration, OIR, glaucoma, and experimental autoimmune uveitis.
Preclinical Ophthalmic Contract Research